Featured article: Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis

Mental illnesses are associated with increased risk of cardiometabolic comorbidities. In this study, Correll et al. evaluate the prevalence of these comorbidities, hospitalisation outcomes and costs among patients with schizophrenia and bipolar disorder. They find that more than 60% of inpatients with these disorders also have cardiometabolic comorbidities, and that increased comorbidity burden was associated with greater likelihood of readmission.

Read the full article here.


View all articles

Aims and scope

Annals of General Psychiatry considers manuscripts on all aspects of psychiatry, including neuroscience and psychological medicine. Both basic and clinical neuroscience contributions are encouraged.

Annals of General Psychiatry emphasizes a biopsychosocial approach to illness and health and strongly supports and follows the principles of evidence-based medicine. As an open access journal, Annals of General Psychiatry facilitates the worldwide distribution of high quality psychiatry and mental health research. The journal considers submissions on a wide range of topics including, but not limited to, psychopharmacology, forensic psychiatry, psychotic disorders, psychiatric genetics, and mood and anxiety disorders.

Featured conference: 5th International Congress on Neurobiology, Psychopharmacology & Treatment Guidance

The International Society of Neurobiology and Psychopharmacology is pleased to announce that the 5th International Congress on Neurobiology, Psychopharmacology & Treatment Guidance, will be held in 25-27 May 2017 in Porto Carras, Chalkidiki, Greece. For more information, please visit the website